Solventum Corporation Common Stock (SOLV)

About SOLV

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

20,584

Website

www.solventum.com

Fundamentals

1-day range

$85.29$89.48

Market cap

$15.25B

P/E (trailing)

10.83

P/E (forward)

12.27

EPS (trailing)

$8.18

Dividend yield

—

Beta

0.67

Avg. volume

1.59M

Forecasts

13 analyst ratings

Solventum Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• SOLV

  Solventum Corporation Common Stock

  $91.12

  ▲ 0.21%
  Market cap $15.25BP/E 10.83
  $62.38$90
• BAX

  Baxter International Inc. Common Stock

  $26.12

  ▲ 0.77%
  Market cap $14.53BP/E —
  $15.73$30
• PODD

  Insulet Corporation Common Stock

  $145.15

  ▲ 1.21%
  Market cap $11.75BP/E 27.05
  $126.4$354.88
• GMED

  Globus Medical Inc. Class A Common Stock

  $83.06

  ▲ 0.63%
  Market cap $11.06BP/E 21.55
  $54.15$101.4
• GKOS

  Glaukos Corporation Common Stock

  $179.56

  ▼ 1.29%
  Market cap $10.08BP/E —
  $73.16$191.62
• APLD

  Applied Digital Corporation Common Stock

  $25.37

  ▼ 7.56%
  Market cap $8.60BP/E —
  $13.16$50.73
• TFX

  Teleflex Incorporated Common Stock

  $139.84

  ▲ 1.55%
  Market cap $6.18BP/E —
  $100.18$145

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
  Yahoo · 8/20/2026
• SOLV Plans Health Information Systems Business Spinoff to Drive Growth
  Yahoo · 8/14/2026
• Are Wall Street Analysts Bullish on Solventum Stock?
  Yahoo · 8/14/2026
• Solventum (SOLV) Q2 2026 Earnings Call Transcript
  Yahoo · 8/13/2026
• Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio: Q2 2026 Update
  SeekingAlpha · 8/12/2026
• SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
  Yahoo · 8/11/2026
• Solventum (SOLV) Stock Fair Value Rises After Q2 And HIS Separation Plans
  Yahoo · 8/9/2026
• Solventum Q2 Earnings Call Highlights
  Yahoo · 8/9/2026

• Shirley Ann Edwards · May 15, 2026 · Grant

  3.3K
• Elizabeth Mily · May 15, 2026 · Grant

  3.3K
• Darryl L. Wilson · May 15, 2026 · Grant

  3.3K
• Susan D. DeVore · May 15, 2026 · Grant

  3.3K
• Carlos Alban · May 15, 2026 · Grant

  3.3K
• Amy McBride Wendell · May 15, 2026 · Grant

  3.3K
• Bernard A. Harris Jr. · May 15, 2026 · Grant

  3.3K
• Glenn A. Eisenberg · May 15, 2026 · Grant

  3.3K
• John H. Weiland · May 15, 2026 · Grant

  3.3K
• Karen J. May · May 15, 2026 · Grant

  3.3K
• Carrie Smith Cox · May 15, 2026 · Grant

  4.8K
• Wayde D. McMillan · May 13, 2026 · Option Exercise

  9.5K
• Wayde D. McMillan · May 13, 2026 · Tax Withholding

  4.4K @ $74.41
• Bryan C. Hanson · May 13, 2026 · Option Exercise

  34.3K
• Bryan C. Hanson · May 13, 2026 · Tax Withholding

  13.5K @ $74.41

Institutional Ownership

March 31, 2026

Total shares held

120.62M

Total value held

$7.70B

Institutional holders

860